FeesSafety
Pluang+

Bank7's acquisition of Century Financial boosts deposits and earnings, with 10-17% share price upside forecast.

Analyst Insights
29 Oct 2026, 22:28 WIB
Seeking Alpha
View Source
Bullish
Bank7's acquisition of Century Financial boosts deposits and earnings, with 10-17% share price upside forecast.

Bank7 Corp. is rated Buy following its acquisition of Century Financial, which adds $1.23 billion in low-cost deposits to support loan growth. The deal is expected to increase earnings per share by 23–27% by 2027, with pro forma EPS projected between $5.75 and $5.95. Bank7 shows strong profitability metrics, including a 21.4% ROATCE and 17.2% annual tangible book value growth from 2021 to 2025. The price target is set at $63–$67 per share, implying a 10–17% upside, though integration risks and Q4 deal costs remain near-term concerns.

Bank7's acquisition of Century Financial is the focus, with Pluang providing a snapshot of the Financials sector as of Oct 30, 2026 01:02 WIB: Among 142 priced US Financials-sector stocks, 110 advanced and 32 declined. Notable movers include MasterCard Inc at USD 635.04 (+4.05%) with a typical hold time of 136 days and 100% buy order activity, CleanSpark Inc at USD 8.24 (-3.96%) with 61% buy activity, and Deutsche Bank AG at USD 34.75 (+3.70%) with 99% sell order activity and a typical hold time of 81 days.

More News

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...

Company Fundamentals
Bullish
3 hours ago
Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals announced on July 30, 2026, that it lowered its full-year 2026 sales guidance for its TTR product by about $200 million due to slower than expected market growth. This caused the stock to fall 28.31%, injuring investors. On Oc...

Market News
Bearish
4 hours ago
Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token price increased by 3.00% within one hour on October 29, reaching $94.82 on Binance. Over the same 24-hour period, HYPE gained 17.28%, reflecting strong upward momentum. During this hour, significant liquidations occurred with...

Market News
Bullish
4 hours ago
Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson is currently trading at a high valuation of 27 times its earnings despite weak operating income and declining sales forecasts projected through 2027. Recent improvements in retail and inventory have not translated into sustainable ear...

Analyst Insights
Bearish
4 hours ago
$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

At least $5.57 billion in cryptocurrency was moved out of Binance-linked wallets across Ethereum, Bitcoin, and Tron blockchains in what appears to be a major security breach. Binance has not confirmed a hack but is actively investigating the potentia...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App